SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-I - Tender offer statement by Issuer:
SEC Accession No. 0001193125-20-290340
Filing Date
2020-11-10
Accepted
2020-11-10 17:27:30
Documents
13

Document Format Files

Seq Description Document Type Size
1 SC TO-I d800199dsctoi.htm SC TO-I 53017
2 EX-(A)(1)(A) d800199dex99a1a.htm EX-99.A1A 261471
3 EX-(A)(1)(B) d800199dex99a1b.htm EX-99.A1B 5385
4 EX-(A)(1)(C) d800199dex99a1c.htm EX-99.A1C 42209
5 EX-(A)(1)(D) d800199dex99a1d.htm EX-99.A1D 14412
6 EX-(A)(1)(E) d800199dex99a1e.htm EX-99.A1E 4652
7 EX-(A)(1)(F) d800199dex99a1f.htm EX-99.A1F 3413
8 EX-(A)(1)(G) d800199dex99a1g.htm EX-99.A1G 3767
9 EX-(A)(1)(H) d800199dex99a1h.htm EX-99.A1H 2978
10 EX-99.A1I d800199dex99a1i.htm EX-99.A1I 2305
11 EX-(A)(1)(J) d800199dex99a1j.htm EX-99.A1J 2362
12 EX-99.A1K d800199dex99a1k.htm EX-99.A1K 3657
13 EX-99.A1L d800199dex99a1l.htm EX-99.A1L 1599
  Complete submission text file 0001193125-20-290340.txt   402841
Mailing Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601 844-445-5704
XERIS PHARMACEUTICALS INC (Filed by) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-I
SIC: 2834 Pharmaceutical Preparations

Mailing Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601 844-445-5704
XERIS PHARMACEUTICALS INC (Subject) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-I | Act: 34 | File No.: 005-90534 | Film No.: 201302283
SIC: 2834 Pharmaceutical Preparations